$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How to take oral semaglutide
2026-02-01 22:25:32
Check Details
Efficacy of oral semaglutide
2026-02-01 22:25:32
Check Details
Canafenib price 2024
2026-02-01 22:25:32
Check Details
What is the function of Canafenib?
2026-02-01 22:25:32
Check Details
How to deal with canafenib resistance
2026-02-01 22:25:32
Check Details
How effective is sparsentin in lowering creatinine?
2026-02-01 22:25:32
Check Details
Comparison of the effects of sparsentan and ambrisentan
2026-02-01 22:25:32
Check Details
Sparsentan: the first and only non-immunosuppressive therapy to reduce proteinuria in IgA nephropathy.
2026-02-01 22:25:32
Check Details
Can sparsentin treat uremia?
2026-02-01 22:25:32
Check Details
What types of nephritis does sparsentan have significant effects on?
2026-02-01 22:25:32
Check Details
Are patients at risk of relapse after treating FSGS nephropathy with sparsentane?
2026-02-01 22:25:32
Check Details
Which thrombocytopenias are specifically indicated for avatrombopag? How effective is it?
2026-02-01 22:25:32
Check Details
1
2
...
889
890
891
892
893
894
895
...
10223
10224
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Eltrombopag Administration Timing and Alternative Therapy Guide
2
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
3
Avatrombopag: A Complete Guide to Dosage, Mechanism, and Clinical Use
4
Tazemetostat Dosage Guide: Laos Generic vs. Original Tazverik Comparison
5
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
6
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
7
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons
8
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
9
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison
10
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
11
Elagolix Side Effects and Safety Guide
12
Hetrombopag vs. Avatrombopag: Key Differences Between Two Oral TPO-RAs and Safety Considerations